Loraz and Acthar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Acthar (corticotropin). Common drug interactions include asthenia among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Acthar. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Acthar?

Acthar has active ingredients of corticotropin. eHealthMe is studying from 4,948 Acthar users. Check the latest studies of Acthar.

On Jul, 19, 2026

42 people who take Loraz and Acthar together, and have interactions are studied.

What are the common drug interactions of Loraz and Acthar, by gender? *:

female:

Asthenia (weakness)
Joint swelling
Peripheral swelling
Diarrhoea
Fatigue (feeling of tiredness)
Influenza
Memory impairment
Nausea (feeling of having an urge to vomit)
Abdominal pain upper
Arthritis (form of joint disorder that involves inflammation of one or more joints)

male:

Alanine aminotransferase increased
Blood pressure decreased
Asthenia (weakness)
Colon cancer
Death
Dyspnoea (difficult or laboured respiration)
Memory impairment
Muscle spasms (muscle contraction)
Nausea (feeling of having an urge to vomit)
Pneumonia

What are the common drug interactions of Loraz and Acthar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Alanine aminotransferase increased
Blood pressure decreased
Diplopia (double vision)
Heart rate increased
Lymphocyte count decreased
Monocyte count increased
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Weight fluctuation
Asthma

40-49:

Fall

50-59:

Asthenia (weakness)
Nausea (feeling of having an urge to vomit)
Erythema (redness of the skin)
Dizziness
Gait disturbance
Joint swelling
Malaise (a feeling of general discomfort or uneasiness)
Peripheral swelling
Vision blurred
Abdominal discomfort

60+:

Injection site bruising
Injection site erythema (redness at injection site)
Alopecia (absence of hair from areas of the body)
Death
Influenza
Macular oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken)
Muscle spasms (muscle contraction)
Nausea (feeling of having an urge to vomit)
Tooth disorder (tooth disease)

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 16 people, 38.10%
Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 8 people, 19.05%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Acthar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously